The Dutch government will drop its last remaining COVID-19 restrictions next week despite a recent rise in infections as the nation learns to live with the coronavirus, officials said Tuesday.
Mar 15, 2022
0
25
The risk of suffering an ischaemic stroke, the most common type of cerebrovascular event, is 16% less in people who have green spaces less than 300 meters from their homes. This has been revealed in a joint study by ...
Mar 15, 2022
0
28
The widespread use of menthol cigarettes in underage smokers has been overlooked according to new research from the University of Stirling and Cardiff University.
Mar 11, 2022
0
17
French-Austrian biotech firm Valneva on Tuesday said its COVID-19 vaccine received emergency authorisation for use in Bahrain, the first approval for its jab.
Mar 1, 2022
0
1
Wanderlust can be a powerful motivator in people's decision to get vaccinated against COVID-19, a new study from Washington State University says.
Feb 25, 2022
0
9
The European Union's drug watchdog Thursday approved Moderna's anti-COVID shot for children aged six to 11, the second vaccine to be approved for younger children in the 27-member bloc.
Feb 24, 2022
0
7
Slovakia's health ministry on Tuesday opened registration for the new COVID jab from Novavax, which experts hope will win over vaccine sceptics as it is made from a more conventional technology.
Feb 15, 2022
0
18
The EU on Monday stood by its refusal to lift patent protections on COVID vaccines, just days ahead of a summit with African Union countries who see the issue as a priority.
Feb 14, 2022
0
2
China on Saturday said it had given "conditional" approval for Pfizer's COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
Feb 12, 2022
0
8
The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19.
Feb 10, 2022
0
2
